Publications
Targeting drug-resistant cancers: in silico repurposing of the cholesterol-lowering drug Ezetimibe for selective inhibition of aldo-keto reductase 1B10 (AKR1B10)
Assessment of Healthcare Professionals’ and Students’ Perspectives and Intentions for Raising Public Awareness and Comprehension of Antimicrobial Resistance
Identification of Bacterial Oligopeptidase B Inhibitors from Microbial Natural Products: Molecular Insights, Docking Studies, MD Simulations, and ADMET Predictions
Pharmacophore-based virtual screening and in silico investigations of small molecule library for discovery of human hepatic ketohexokinase inhibitors for the treatment of fructose metabolic disorders
Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors
Computational investigations of flavonoids as ALDH isoform inhibitors for treatment of cancer
Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors
Emerging therapeutics: The imidazo[1,2-b]pyridazine scaffold as a novel drug candidate for eumycetoma, a neglected tropical disease
Flavonostilbenes natural hybrids from Rhamnoneuron balansae as potential antitumors targeting ALDH1A1: molecular docking, ADMET, MM-GBSA calculations and molecular dynamics studies
Turning down PI3K/AKT/mTOR signalling pathway by natural products: an in silico multi-target approach
A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis
Isatin derivatives as broad-spectrum antiviral agents: the current landscape
Bioinspired imidazo[1,2-a:4,5-c?]dipyridines with dual antiproliferative and anti-migrative properties in human cancer cells: The SAR investigation
Schiff Bases of Isatin and Adamantane-1-Carbohydrazide: Synthesis, Characterization and Anticonvulsant Activity
Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects